Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 4836s-4841s, October 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gillette, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillette, E. L.

Clinical Use of Thermal Enhancement and Therapeutic Gain for Hyperthermia Combined with Radiation or Drugs1

Edward L. Gillette

Department of Radiology and Radiation Biology, Comparative Oncology Unit, Colorado State University, Fort Collins, Colorado 80523

Values for thermal enhancement and therapeutic gain are useful for deciding future directions of hyperthermia combined with other cancer therapy modalities. Evidence of thermal enhancement of effects on normal tissues is important as it indicates the need for dose modification. Specific values cannot be used generally to determine the degree of dose modification for clinical applications. A range of values accounting for many variables, including method of dose delivery for heat and the other modalities and knowledge of the normal tissues at risk, would be required for such specific application. There is frequently hyperthermic enhancement of radiation damage to acutely responding tissues. That may be avoided if tumors can be selectively heated, but extensive temperature monitoring is necessary to avoid hot spots. Irradiation and heating of spontaneous canine tumors resulted in an increased probability for tumor control with no apparent increase in late complications. Human clinical studies have shown that, with care, tumor response can be enhanced without significantly increasing normal tissue damage and that a therapeutic gain can be achieved. Caution must be exercised because, with few exceptions, follow-up was not long, and the tissues at risk were limited. Most human studies have been of relatively superficial tumors of small volume. Little information is available on whole-body or regional hyperthermia for assessment of thermal enhancement or therapeutic gain. Also, there is little information about chemotherapy combined with heat, although studies of heat with perfusion chemotherapy for malignant melanomas of the extremity have shown significantly increased survival rates.

1 Presented at the Workshop Conference on Hyperthermia in Cancer Treatment, March 19 to 21, 1984, Tucson, AZ. This work was supported in part by USPHS Grant CA29582, Department of Health and Human Services.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.